Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AFIB |
---|---|---|
10:09 ET | 2700 | 0.074 |
10:11 ET | 900 | 0.0704 |
10:29 ET | 25000 | 0.074 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Acutus Medical Inc | 2.0M | -0.5x | --- |
Lancer Orthodontics Inc | 83.1K | 0.7x | -9.28% |
Encision Inc | 5.0M | -7.0x | --- |
SETO Holdings Inc | 592.0K | -0.1x | --- |
Hemagen Diagnostics Inc | 20.0 | 0.0x | --- |
Biomerica Inc | 5.3M | -0.9x | --- |
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0M |
---|---|
Revenue (TTM) | $15.4M |
Shares Outstanding | 29.8M |
Acutus Medical Inc does not pay a dividend. | |
Beta | -0.12 |
EPS | $-0.16 |
Book Value | $-0.03 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -9.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.